To confirm these data, primary CRC cells from Pt 93 and Pt 130 were treated with 0.2 μM TVB-3664 for 6 days in normal or serum-starved conditions and labeled with CD36-FITC antibody. Here, CD36 is linked to colorectal carcinoma.